The estimated Net Worth of Scott Peter Seidelmann is at least $12.4 Миллион dollars as of 27 December 2022. Mr. Seidelmann owns over 945 units of Omnicell stock worth over $1,282,969 and over the last 7 years he sold OMCL stock worth over $8,476,184. In addition, he makes $2,670,700 as Executive Vice President and Chief Commercial Officer at Omnicell.
Scott has made over 15 trades of the Omnicell stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 945 units of OMCL stock worth $45,625 on 27 December 2022.
The largest trade he's ever made was selling 41,878 units of Omnicell stock on 5 August 2021 worth over $6,409,428. On average, Scott trades about 2,652 units every 44 days since 2018. As of 27 December 2022 he still owns at least 29,788 units of Omnicell stock.
You can see the complete history of Mr. Seidelmann stock trades at the bottom of the page.
Scott P. Seidelmann is Executive Vice President and Chief Commercial Officer of the company. He joined Omnicell in April 2018 as Executive Vice President and Chief Commercial Officer. Prior to joining Omnicell, from January 2015 to August 2017, Mr. Seidelmann served as founder and Chief Executive Officer of Candescent Health, Inc., a cloud-based radiology workflow and analytics provider. From 2005 to 2014, Mr. Seidelmann served as co-founder and Chief Executive Officer of Radisphere, Inc., a national radiology practice, prior to its acquisition by Sheridan Healthcare. Earlier in his career, Mr. Seidelmann held positions with Merrill Lynch and Ericsson Venture Partners. Mr. Seidelmann received a B.A. from Cornell University.
As the Executive Vice President and Chief Commercial Officer of Omnicell, the total compensation of Scott Seidelmann at Omnicell is $2,670,700. There are 2 executives at Omnicell getting paid more, with Randall Lipps having the highest compensation of $7,208,970.
Scott Seidelmann is 44, he's been the Executive Vice President and Chief Commercial Officer of Omnicell since 2018. There are 19 older and no younger executives at Omnicell. The oldest executive at Omnicell, Inc. is Sara White, 74, who is the Independent Director.
Over the last 21 years, insiders at Omnicell have traded over $118,258,750 worth of Omnicell stock and bought 526,030 units worth $5,215,749 . The most active insiders traders include William H Jr Younger, Randall A Lipps и Benjamin A Horowitz. On average, Omnicell executives and independent directors trade stock every 10 days with the average trade being worth of $482,255. The most recent stock trade was executed by Christine Marie Mellon on 9 June 2023, trading 7,951 units of OMCL stock currently worth $581,536.
since 1992, omnicell has been creating new efficiencies to improve patient care, anywhere it is delivered. omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. omnicell’s automated hardware/software systems for medication dispensing include solutions from the point of entry into the hospital through the central pharmacy, nursing unit, operating room, and patient bedside. our supply management systems promote greater cost control and charge capture for payer reimbursement, and improve management and reordering of inventory. omnicell® products range from high-security, closed-cabinet systems and software to open-shelf and combination systems in the nursing unit, cath lab, and operating room. more than 3,200 customers worldwide have utilized omnice
Omnicell executives and other stock owners filed with the SEC include: